Evidence map›Paper›PMID 32585805›Full record

ReviewPathogens (Basel, Switzerland)2020

Emerging Prevention and Treatment Strategies to Control COVID-19.

Vipul K Singh, Abhishek Mishra, Shubhra Singh, Premranjan Kumar, Manisha Singh, Chinnaswamy Jagannath, Arshad Khan

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. International, national and local trends in the spread of COVID-19: a geographic view of COVID-19 spread and the role to be played by coproduction.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vipul K SinghDepartment of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0002-7146-7279
Abhishek MishraDepartment of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Shubhra SinghDepartment of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Premranjan KumarDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Manisha SinghDepartment of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Chinnaswamy JagannathDepartment of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Arshad KhanDepartment of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0003-3655-2854

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has now become a serious global threat after inflicting more than 8 million infections and 425,000 deaths in less than 6 months. Currently, no definitive treatment or prevention therapy exists for COVID-19. The unprecedented rise of this pandemic has rapidly fueled research efforts to discover and develop new vaccines and treatment strategies against this novel coronavirus. While hundreds of vaccines/therapeutics are still in the preclinical or early stage of clinical development, a few of them have shown promising results in controlling the infection. Here, in this review, we discuss the promising vaccines and treatment options for COVID-19, their challenges, and potential alternative strategies.

Indexed as

convalescent plasmaCOVID-19drug repurposingSARS-CoV-2stem cell therapyvaccine interventions

Identifiers

PMID32585805
PMCPMC7350294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.